首页> 外国专利> Low-toxicity intravenous immunosuppressive medicament comprising fusidic acid, useful for suppressing graft-versus-host reactions and treating environmental diseases such as occupational dermatosis

Low-toxicity intravenous immunosuppressive medicament comprising fusidic acid, useful for suppressing graft-versus-host reactions and treating environmental diseases such as occupational dermatosis

机译：包含夫西地酸的低毒性静脉免疫抑制药物，可用于抑制移植物抗宿主反应和治疗环境疾病，例如职业性皮肤病

页面导航

摘要
著录项
相似文献

摘要

Fusidic acid (I) (a tetracyclic triterpenoid acid) is used in the systemic (specifically intravenous) therapy of environmental diseases and as an intravenous immunosuppressive medicament having a similar spectrum of activity to cyclosporin A.

机译：夫西地酸（I）（四环三萜酸）用于环境疾病的全身性（特别是静脉内）治疗，并用作具有与环孢菌素A相似活性的静脉内免疫抑制药物。

著录项

公开/公告号DE10130819A1

专利类型
公开/公告日2002-10-17

原文格式PDF
申请/专利权人 DOEHRING MARTIN;
展开▼

申请/专利号DE2001130819
发明设计人 DOEHRING MARTIN;
展开▼

申请日2001-06-26
分类号A61K31/575;C07J9/00;
国家 DE
入库时间 2022-08-22 00:26:53

相似文献

专利
外文文献
中文文献